AmerStem Inc.
AmerStem develops and operates a plant-based biotechnology platform for indoor cultivation and scalable production of plant-derived bioactive compounds. The company focuses on sustainable, resource-efficient biomass growth and green extraction methods to produce saponin immunoadjuvants and other phytochemicals for vaccine development, pharmaceuticals, agriculture, and personal care.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Saponin immunoadjuvant extracts (QS-21 class)
Purified saponin-class immunoadjuvant extracts produced via cultivated plant biomass and green extraction workflows; intended as an alternative source to wild-harvested tree-derived saponins.
AmerStem plant culture technology platform
A sustainable, modular, and scalable plant culture technology platform designed for bioactives secretion into liquid culture media with an aeroponics component, superior biomass growth, and enhanced secondary metabolite production such as saponins.
GMP QS-21
A high-value saponin extracted from Quillaja trees, used as a potent immunoadjuvant for vaccine manufacturing.
proprietary functional technology platform for large-scale production of saponin immunoadjuvants
A proprietary technology platform developed by AmerStem for sustainable and large-scale production of saponin immunoadjuvants, including QS-21, using plant-derived saponins.
Saponin immunoadjuvant extracts (QS-21 class)
Purified saponin-class immunoadjuvant extracts produced via cultivated plant biomass and green extraction workflows; intended as an alternative source to wild-harvested tree-derived saponins.
AmerStem plant culture technology platform
A sustainable, modular, and scalable plant culture technology platform designed for bioactives secretion into liquid culture media with an aeroponics component, superior biomass growth, and enhanced secondary metabolite production such as saponins.
GMP QS-21
A high-value saponin extracted from Quillaja trees, used as a potent immunoadjuvant for vaccine manufacturing.
proprietary functional technology platform for large-scale production of saponin immunoadjuvants
A proprietary technology platform developed by AmerStem for sustainable and large-scale production of saponin immunoadjuvants, including QS-21, using plant-derived saponins.
Services
Provision of controlled-environment cultivation services to grow plant biomass at commercial scale for extraction of targeted phytochemicals.
Green extraction and downstream purification services for recovery of high-value phytochemicals, including saponin-class immunoadjuvants.
Collaborative R&D programs to optimize plant culture systems, increase target metabolite yields, and translate plant-derived compounds into applications such as vaccine adjuvants and crop protection agents.
Provision of controlled-environment cultivation services to grow plant biomass at commercial scale for extraction of targeted phytochemicals.
Green extraction and downstream purification services for recovery of high-value phytochemicals, including saponin-class immunoadjuvants.
Collaborative R&D programs to optimize plant culture systems, increase target metabolite yields, and translate plant-derived compounds into applications such as vaccine adjuvants and crop protection agents.
Expertise Areas
- Plant cell and tissue culture
- Indoor/vertical farming for biomass production
- Biopharming and plant-based recombinant protein production
- Saponin immunoadjuvant production
Key Technologies
- Hairy root culture
- Plant cell and tissue culture
- Indoor controlled-environment agriculture / vertical farming
- Elicitor-based induction of secondary metabolism